ImmunityBio Inc. Common Stock vs Mitsubishi UFJ Financial Group Inc. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.03 (market cap $10.51B), while Mitsubishi UFJ Financial Group Inc. Common Stock trades at $22 (market cap $249.48B). The key difference: Mitsubishi UFJ Financial Group Inc. Common Stock is far larger — about 23.7× ImmunityBio Inc. Common Stock's market cap, and Mitsubishi UFJ Financial Group Inc. Common Stock pays a 2.4% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Mitsubishi UFJ Financial Group Inc. Common Stock for 0 Days on average.
| IBRX | MUFG | |
|---|---|---|
Market Cap | $10.51B | $249.48B |
Volume | 10,445,785 | 4,008,160 |
Sector | Health | Financials |
52-Week High | $11.55 | $24.13 |
52-Week Low | $1.98 | $14.62 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.97B | $28.96T |
Dividend Yield | — | 2.4% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Mitsubishi UFJ Financial Group is a Japanese financial services company providing banking, lending, securities, and asset management services. Its businesses serve individuals, companies, and institutions worldwide.
Read more on MUFG →